Editorial · 25 Mar 2022
Conference abstractPublished 5 Aug 2013
Mut-map, a high-throughput micro fluidics chip-based mutation detection panel
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
With the advent of personalized medicine, the need for molecular profiling of the tumor samples - such as detecting oncogenic mutations or profiling gene expression profiling - has taken center stage in the treatment of cancer. Commercially available tests are usually designed for detecting hotspot mutations detect specific mutations in a single targeted gene such as BRAF, KRAS or EGFR and require relatively large amount of DNA for testing. On the other hand, although Next-Generation Sequencing (NGS) can profile entire genomes, high costs, and complex data analysis requirements and, high turnaround times render the technology not being suited for routine analysis. We have developed a micro fluidic chip based high-throughput platform for detecting over 120 hotspot mutations across 11 genes using 2-100 ng of DNA extracted from formalin-fixed paraffin-embedded tissues. The genes targeted on this panel include AKT1, BRAF, EGFR, FGFR3, FLT3, HRAS, KIT, KRAS, MET, NRAS , and PIK3CA . Allele-specific PCR (AS-PCR) has been optimized to detect the hotspot mutations using the Fluidigm micro fluidic chip. Automated data analysis has been integrated to the mutation detection workflow. This MUT-MAP assay is designed to analyze mutation status in 88-132 samples per day. Platform validation including assay cross-reactivity studies were performed using synthetic oligomers as well as cell line DNA with known mutations reported in the COSMIC database. The assay sensitivity for the above assays range from 1-4%. This platform is routinely used in our lab to detect mutations in clinical samples and provide a valuable platform for exploratory biomarker assessments during drug development.
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference proceeding · 25 Aug 2021
Mutation Detection via CRISPRCas9 Micro-fluid Chip
Conference abstract · 28 Mar 2022
Micro fluidic chip that able to purify a Viral Nucleic Acid without any chemical reactions
Perspective · 21 Feb 2025
Clinical Advantages and Techniques Involved in High-Throughput Analysis of Glycans
Perspective · 2023
Clinical Advantages and Techniques Involved in High-Throughput Analysis of Glycans
More from this journal
The newest in Translational Medicine.
Opinion · 25 Jun 2026
Radiomics in Translational Medicine for Quantitative Imaging and Personalized Clinical Assessment
Opinion · 25 Jun 2026
Digital Twin Technology in Translational Medicine for Individualized Disease Simulation and Clinical Planning
Opinion · 25 Jun 2026
Proteomic Signatures in Translational Medicine for Disease Stratification and Therapeutic Evaluation
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalTranslational Medicine
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Rajesh D Patel”

